<DOC>
	<DOCNO>NCT00445107</DOCNO>
	<brief_summary>The purpose study assess treatment effect montelukast 10mg primary endpoint Asthma Control Questionnaire ( ACQ ) , 8-week period , persistent asthma patient without allergic rhinitis .</brief_summary>
	<brief_title>SINGULAIR ( R ) Complementary Therapy Fixed Association Regimen ( 0476-363 )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Patient currently nonsmoker nonsmoker least 1 year Patient clinical evidence mild/moderate asthma without allergic rhinitis Patient treat emergency room asthma within 4 week hospitalize asthma within 3 month prior visit 1 Patient severe asthma , upper respiratory infection , sinusitis , infectious rhinitis , nonallergic rhinitis Patient active , acute , chronic pulmonary disorder document history , physical examination</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>